MYH14 and ocular melanoma: OM and piperine were chosen in this study for the following reasons: OM was the first myosin activator to undergo, ultimately unsuccessful, clinical trials as a myosin activator (25), but it was also shown to have inhibitory effects on myosin ATPase in the absence of actin (26).